PW Medtech Advances Sichuan Ruijian Medical Spin-off

PW Medtech Group Ltd. (HK:1358) has released an update.

PW Medtech Group Ltd. has announced progress on the proposed spin-off of its subsidiary, Sichuan Ruijian Medical, which has been approved for public transfer and quotation on the NEEQS. The completion of this process is expected by October 31, 2024, with potential for a subsequent listing, depending on market conditions and strategic needs. Shareholders and investors are cautioned that the spin-off is contingent upon market conditions and regulatory approvals, and there are no guarantees on its materialization or timing.

For further insights into HK:1358 stock, check out TipRanks’ Stock Analysis page.